Insmed (0JAV) Ratios
Insmed Ratios
GB:0JAV's free cash flow for Q3 2026 was $-42.09M. For the 2026 fiscal year, GB:0JAV's free cash flow was decreased by $-5.63M and operating cash flow was $-36.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.83 | 5.45 | 4.12 | 6.69 | 6.19 |
| Quick Ratio | 3.54 | 5.12 | 3.75 | 6.33 | 5.70 |
| Cash Ratio | 1.09 | 1.87 | 2.14 | 5.65 | 5.30 |
| Solvency Ratio | -0.83 | -0.52 | -0.44 | -0.30 | -0.50 |
| Operating Cash Flow Ratio | -1.99 | -2.30 | -2.38 | -2.10 | -2.69 |
| Short-Term Operating Cash Flow Coverage | -48.54 | -41.46 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 268.63M | $ -118.19M | $ -732.70M | $ -295.10M | $ 4.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.65 | 0.91 | 0.71 | 0.49 |
| Debt-to-Equity Ratio | 1.04 | 4.60 | -3.63 | 13.39 | 1.49 |
| Debt-to-Capital Ratio | 0.51 | 0.82 | 1.38 | 0.93 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 0.49 | 0.82 | 1.40 | 0.93 | 0.58 |
| Financial Leverage Ratio | 3.06 | 7.10 | -4.01 | 18.83 | 3.03 |
| Debt Service Coverage Ratio | -11.42 | -8.11 | -8.11 | -16.97 | -9.44 |
| Interest Coverage Ratio | -14.04 | -10.34 | -8.69 | -17.29 | -9.27 |
| Debt to Market Cap | 0.02 | 0.11 | 0.27 | 0.46 | 0.19 |
| Interest Debt Per Share | 3.99 | 8.53 | 9.16 | 9.79 | 5.82 |
| Net Debt to EBITDA | -0.22 | -0.93 | -1.09 | -0.23 | 0.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 79.41% | 76.43% | 78.52% | 77.53% | 76.57% |
| EBIT Margin | -195.90% | -228.15% | -219.77% | -186.54% | -211.09% |
| EBITDA Margin | -193.18% | -225.12% | -216.30% | -182.33% | -203.57% |
| Operating Profit Margin | -194.04% | -241.47% | -232.51% | -186.39% | -199.03% |
| Pretax Profit Margin | -209.71% | -250.22% | -244.76% | -195.69% | -231.57% |
| Net Profit Margin | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
| Continuous Operations Profit Margin | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
| Net Income Per EBT | 100.40% | 100.41% | 100.34% | 100.29% | 99.60% |
| EBT Per EBIT | 108.07% | 103.62% | 105.27% | 104.99% | 116.35% |
| Return on Assets (ROA) | -56.38% | -45.12% | -56.37% | -29.07% | -34.95% |
| Return on Equity (ROE) | -172.78% | -320.20% | 225.83% | -547.50% | -105.89% |
| Return on Capital Employed (ROCE) | -65.53% | -50.83% | -64.27% | -31.19% | -33.84% |
| Return on Invested Capital (ROIC) | -64.84% | -50.35% | -63.65% | -31.02% | -33.40% |
| Return on Tangible Assets | -62.87% | -49.92% | -66.33% | -33.17% | -42.05% |
| Earnings Yield | -3.43% | -8.07% | -17.22% | -19.59% | -14.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.31 | 6.99 | 7.41 | 8.26 | 7.74 |
| Payables Turnover | 1.56 | 1.17 | 1.00 | 1.09 | 1.23 |
| Inventory Turnover | 0.95 | 0.87 | 0.79 | 0.79 | 0.66 |
| Fixed Asset Turnover | 4.36 | 3.15 | 2.92 | 2.40 | 1.97 |
| Asset Turnover | 0.27 | 0.18 | 0.23 | 0.15 | 0.15 |
| Working Capital Turnover Ratio | 0.46 | 0.36 | 0.34 | 0.27 | 0.31 |
| Cash Conversion Cycle | 237.24 | 160.94 | 148.64 | 173.06 | 305.30 |
| Days of Sales Outstanding | 84.78 | 52.20 | 49.26 | 44.20 | 47.16 |
| Days of Inventory Outstanding | 386.02 | 419.64 | 463.38 | 462.97 | 553.96 |
| Days of Payables Outstanding | 233.56 | 310.90 | 364.00 | 334.11 | 295.82 |
| Operating Cycle | 470.81 | 471.84 | 512.64 | 507.17 | 601.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.38 | -4.17 | -3.82 | -3.25 | -3.24 |
| Free Cash Flow Per Share | -4.53 | -4.30 | -3.91 | -3.33 | -3.31 |
| Dividend Paid and CapEx Coverage Ratio | -28.72 | -31.19 | -40.36 | -40.54 | -49.84 |
| Capital Expenditure Coverage Ratio | -28.72 | -31.19 | -40.36 | -40.54 | -49.84 |
| Operating Cash Flow Coverage Ratio | -1.22 | -0.52 | -0.45 | -0.34 | -0.59 |
| Operating Cash Flow to Sales Ratio | -1.54 | -1.88 | -1.76 | -1.63 | -1.93 |
| Free Cash Flow Yield | -2.60% | -6.23% | -12.63% | -16.69% | -12.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -27.15 | -12.39 | -5.81 | -5.11 | -7.03 |
| Price-to-Sales (P/S) Ratio | 61.31 | 31.14 | 14.26 | 10.02 | 16.20 |
| Price-to-Book (P/B) Ratio | 50.31 | 39.69 | -13.11 | 27.95 | 7.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -38.43 | -16.05 | -7.92 | -5.99 | -8.24 |
| Price-to-Operating Cash Flow Ratio | -39.77 | -16.56 | -8.12 | -6.14 | -8.41 |
| Price-to-Earnings Growth (PEG) Ratio | -1.80 | -2.88 | -0.16 | -6.60 | -0.24 |
| Enterprise Value Multiple | -31.96 | -14.76 | -7.69 | -5.73 | -7.69 |
| Enterprise Value | 37.44B | 12.08B | 5.07B | 2.56B | 2.95B |
| EV to EBITDA | -31.96 | -14.76 | -7.69 | -5.73 | -7.69 |
| EV to Sales | 61.74 | 33.23 | 16.62 | 10.44 | 15.65 |
| EV to Free Cash Flow | -38.69 | -17.12 | -9.23 | -6.24 | -7.96 |
| EV to Operating Cash Flow | -40.04 | -17.67 | -9.46 | -6.40 | -8.12 |
| Tangible Book Value Per Share | 2.36 | 0.55 | -3.79 | -0.95 | 1.79 |
| Shareholders’ Equity Per Share | 3.46 | 1.74 | -2.36 | 0.71 | 3.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Revenue Per Share | 2.84 | 2.22 | 2.17 | 1.99 | 1.68 |
| Net Income Per Share | -5.98 | -5.57 | -5.34 | -3.91 | -3.88 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.07 | 1.10 | 1.11 | 1.05 | 1.10 |
| Research & Development to Revenue | 1.27 | 1.65 | 1.87 | 1.62 | 1.45 |
| SG&A to Revenue | 1.16 | 1.27 | 1.13 | 1.08 | 1.24 |
| Stock-Based Compensation to Revenue | 0.25 | 0.27 | 0.25 | 0.24 | 0.24 |
| Income Quality | 0.73 | 0.75 | 0.72 | 0.83 | 0.84 |
Currency in USD